G4: (b)(6) 2021.B4: (b)(6) 2021.Further information provided by the reporter revealed initiation date of therapy on the v60 ventilator (b)(6), as (b)(6) 2020.No harm, injury, or allegation of malfunction was noted during therapy duration with cessation of positive pressure ventilation occurring on (b)(6) 2021.It was noted that approximately 18 days after the termination of positive pressure therapy via the v60 ventilator, the patient expired with a primary cause of uremia due to acute renal failure.Due to absence of allegation or malfunction of the v60 ventilator, no device evaluation has been requested by the reporter or customer.Based upon the information provided by the reporter and customer, no allegation of malfunction or failure to meet manufacturer declared specifications was found.The v60 ventilator was not in clinical or therapeutic use on a patient during the time of the patient expiration.No causal or contributory relationship has been alleged or found between the device performance and patient death.The root cause has been determined to be patient condition related with the primary cause of uremia due to acute renal failure resulting in the patient death.Submission of a report does not constitute an admission that medical personnel, user facility, importer, distributor, manufacturer, or product caused or contributed to the event.
|